Sotera Health
SHC | NASDAQ
$18.70
-$0.03 (-0.16%)
At close: Sep 21, 2026, 4:00 PM ET
$18.44
-$0.26 (-1.39%)
After-hours:
Sep 21, 2026, 7:56 PM ET
Company Profile
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Key Executives
| Name | Position |
|---|---|
| Alton E. Shader | CEO & Director |
| Jonathan Lyons | Senior Vice President & Chief Financial Officer |
| Kristin A. Gibbs | Chief Marketing Officer |
| Robert G. Hauzie | Chief Information Officer |
| Danielle J. Menture | Senior Vice President of Global Environmental, Health & Safety and Sustainability |
| Erika Ostrowski | Senior VP, General Counsel & Corporate Secretary |
| Michael Petras Jr. | Executive Chairman of the Board |
| Michael Rutz | President of Sterigenics U.S., LLC |
| Sally R. Turner | Chief Human Resources Officer |
| William Lehmann Jr. | Senior Vice President of Strategy & Corporate Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 19, 2026 | 4 | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 14, 2026 | 8-K | Current Report |
| Aug 11, 2026 | 4 | Filing |
| Aug 07, 2026 | 4 | Filing |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jul 30, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| May 29, 2026 | SD | Filing |
Sotera Health
| Country | United States |
| IPO Date | Nov 19, 2020 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 3,000 |
| CEO | Alton E. Shader |
Contact Details
9100 South Hills Boulevard Broadview Heights,
Ohio 44147 United States
Stock Details
| Ticker Symbol | SHC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001822479 |
| CUSIP Number | 83601L102 |
| ISIN Number | US83601L1026 |
| SIC Code | 8090 |
Recent News
- 3 days ago / seekingalpha.comSotera Health: Pricing Power And Recurring Revenues Are Growth Drivers
- 13 days ago / seekingalpha.comSotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
- 27 days ago / defenseworld.netBlackRock Inc. Invests $428.63 Million in Sotera Health Company $SHC
- 1 month ago / defenseworld.netBank of America Corp DE Buys 991,620 Shares of Sotera Health Company $SHC
- 2 months ago / marketbeat.comSotera Health Q2 Earnings Call Highlights
- 2 months ago / seekingalpha.comSotera Health Company (SHC) Q2 2026 Earnings Call Transcript
- 2 months ago / zacks.comSotera Health (SHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- 2 months ago / globenewswire.comSotera Health Announces Second-Quarter 2026 Earnings Release Date
- 4 months ago / seekingalpha.comSotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
- 4 months ago / seekingalpha.comSotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Add to Watchlist
Select watchlists to add or remove SHC